Beximco Pharmaceuticals (LON:BXP) Shares Up 16.4% - Here's Why

Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report)'s stock price shot up 16.4% on Friday . The stock traded as high as GBX 32 ($0.42) and last traded at GBX 32 ($0.42). 92,950 shares changed hands during trading, a decline of 44% from the average session volume of 167,168 shares. The stock had previously closed at GBX 27.50 ($0.36).

Beximco Pharmaceuticals Trading Up 16.4 %

The stock has a market capitalization of £142.76 million, a PE ratio of 400.00 and a beta of 0.61. The company has a current ratio of 1.80, a quick ratio of 0.37 and a debt-to-equity ratio of 14.73. The business's 50-day moving average is GBX 27.07 and its two-hundred day moving average is GBX 34.48.

Beximco Pharmaceuticals Company Profile

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.